Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy

被引:10
作者
Yu, Guizhen [1 ,2 ,3 ,4 ,5 ]
Cheng, Jun [1 ,2 ,3 ,4 ,5 ]
Jiang, Yan [1 ,2 ,3 ,4 ,5 ]
Li, Heng [1 ,2 ,3 ,4 ,5 ]
Li, Xiayu [1 ,2 ,3 ,4 ,5 ]
Chen, Jianghua [1 ,2 ,3 ,4 ,5 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Kidney Dis Ctr, Hangzhou, Peoples R China
[2] Key Lab Kidney Dis Prevent & Control Technol, Hangzhou, Zhejiang, Peoples R China
[3] Natl Key Clin Dept Kidney Dis, Hangzhou, Peoples R China
[4] Zhejiang Univ, Inst Nephrol, Hangzhou, Peoples R China
[5] Adm Tradit Chinese Med, Grade Lab Natl State 3, Hangzhou, Peoples R China
关键词
IgA nephropathy; kidney disease progression; serum calcium; serum phosphorus; IGA NEPHROPATHY; MINERAL METABOLISM; HEMODIALYSIS-PATIENTS; RISK STRATIFICATION; DIALYSIS OUTCOMES; PRACTICE PATTERNS; RENAL SURVIVAL; BONE DISORDER; MORTALITY; ASSOCIATION;
D O I
10.1093/ckj/sfab002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Disorders of calcium and phosphorus metabolism have been reported to be associated with all-cause and cardiovascular mortality in patients requiring long-term dialysis therapy. However, its role in disease progression is not well established in patients without dialysis, especially in immunoglobulin A (IgA) nephropathy. We aim to evaluate the association of serum phosphorus and calcium and progression of IgA nephropathy. Methods. We assessed 2567 patients with IgA nephropathy at the First Affiliated Hospital, College of Medicine, Zhejiang University. Serum phosphorus and calcium were collected at the time of kidney biopsy and at each visit. The associations of serum phosphorus and serum calcium with composite kidney disease progression events, defined as 50% estimated glomerular filtration rate (eGFR) decline and kidney failure, were examined using Cox models and restricted cubic splines. Results. During a median follow-up of 31.9 months, 248 (10%) patients reached composite kidney disease progression events. A linear relationship was observed between serum phosphorus and composite kidney disease progression events. With higher levels of phosphorus, the risk of kidney disease progression events increased {hazard ratio [HR] 3.54 [95% confidence interval (CI) 1.37-9.12]; P=0.009}. Compared with the first quartile group, the HR of kidney disease progression events was 1.66 (95% CI 0.91-301) for the second quartile, 1.67 (95% CI 0.91-3.08) for the third and 2.62 (95% CI 1.44-4.77) for the fourth (P for trend = 0.002). The association between serum phosphorus and kidney disease progression was detectable [HR 8.94 (95% CI 2.33-34.21); P=0.001] within the subgroup with eGFR <60 mL/min/1.73 m(2) but not among patients with eGFR >= 60 mL/min/1.73 m(2) [HR 0.87 (95% CI 0.17-4.44); P=0.87]. After adjustment for traditional risk factors, a higher level of serum calcium was not associated with kidney disease progression events [HR 0.33 (95% CI 0.10-1.09)]. Conclusions. Higher serum phosphorus rather than serum calcium was independently associated with kidney disease progression in IgA nephropathy.
引用
收藏
页码:2108 / 2113
页数:6
相关论文
共 32 条
[1]   The MEST score provides earlier risk prediction in IgA nephropathy [J].
Barbour, Sean J. ;
Espino-Hernandez, Gabriela ;
Reich, Heather N. ;
Coppo, Rosanna ;
Roberts, Ian S. D. ;
Feehally, John ;
Herzenberg, Andrew M. ;
Cattran, Daniel C. .
KIDNEY INTERNATIONAL, 2016, 89 (01) :167-175
[2]   Risk Stratification of Patients With IgA Nephropathy [J].
Barbour, Sean J. ;
Reich, Heather N. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (06) :865-873
[3]   Predicting the Risk for Dialysis or Death in IgA Nephropathy [J].
Berthoux, Francois ;
Mohey, Hesham ;
Laurent, Blandine ;
Mariat, Christophe ;
Afiani, Aida ;
Thibaudin, Lise .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (04) :752-761
[4]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[5]   Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy [J].
Chen, Pei ;
Yu, Guizhen ;
Zhang, Xue ;
Xie, Xinfang ;
Wang, Jinwei ;
Shi, Sufang ;
Liu, Lijun ;
Lv, Jicheng ;
Zhang, Hong .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10) :1458-1465
[6]   Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome [J].
D'Amico, G .
SEMINARS IN NEPHROLOGY, 2004, 24 (03) :179-196
[7]   Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies [J].
Da, Jingjing ;
Xie, Xinfang ;
Wolf, Myles ;
Disthabanchong, Sinee ;
Wang, Jinwei ;
Zha, Yan ;
Lv, Jicheng ;
Zhang, Luxia ;
Wang, Haiyan .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (02) :258-265
[8]  
Floege J, 2019, KIDNEY INT, V95, P268, DOI 10.1016/j.kint.2018.10.018
[9]  
Foley RN, 2013, NAT REV NEPHROL, V9, P438
[10]   Abnormal Mineral Metabolism and Mortality in Hemodialysis Patients With Secondary Hyperparathyroidism: Evidence From Marginal Structural Models Used to Adjust for Time-Dependent Confounding [J].
Fukagawa, Masafumi ;
Kido, Ryo ;
Komaba, Hirotaka ;
Onishi, Yoshihiro ;
Yamaguchi, Takuhiro ;
Hasegawa, Takeshi ;
Kurita, Noriaki ;
Fukuma, Shingo ;
Akizawa, Tadao ;
Fukuhara, Shunichi .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (06) :979-987